Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Miller L < Miller M < Miller P

Michael A. Miller
Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA
001876
NONE
001876
Michael D. Miller
Clinical Virology, Gilead Sciences, Inc., Foster City, CA
001B02
Department of Antiviral Research, Department of Molecular Systems, Department of Cardiovascular Diseases, Merck ResearchLaboratories, West Point, Pennsylvania 19486-0004, and Department of Medicine/Division of Infectious Diseases, University ofPittsburgh, Pittsburgh, Pennsylvania 15261
001A54
NONE
001A54
001B02
 Department of Antiviral Research, Merck Research Laboratories.
001A54
 To whom correspondence should be addressed:  Department ofAntiviral Research, Merck and Co., Inc., P.O. Box 4, WP42-209, WestPoint, PA 19486-0004. Telephone:  215-652-0480. Fax:  215-993-5798.E-mail:  michael_miller1@merck.com.
001A54
Mitchell D. Miller
Joint Center for Structural Genomics (JCSG)
001470
NONE
001470
Stanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California
001470

<g>
<k>Miller M</k>
<l>
<g>
<k>Michael A. Miller</k>
<l>
<g>
<k>
<mods:affiliation>Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA</mods:affiliation>
</k>
<l>
<i>001876</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>001876</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>Michael D. Miller</k>
<l>
<g>
<k>
<mods:affiliation>Clinical Virology, Gilead Sciences, Inc., Foster City, CA</mods:affiliation>
</k>
<l>
<i>001B02</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Department of Antiviral Research, Department of Molecular Systems, Department of Cardiovascular Diseases, Merck ResearchLaboratories, West Point, Pennsylvania 19486-0004, and Department of Medicine/Division of Infectious Diseases, University ofPittsburgh, Pittsburgh, Pennsylvania 15261</mods:affiliation>
</k>
<l>
<i>001A54</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>001A54</i>
<i>001B02</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>
<mods:affiliation> Department of Antiviral Research, Merck Research Laboratories.</mods:affiliation>
</k>
<l>
<i>001A54</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation> To whom correspondence should be addressed:  Department ofAntiviral Research, Merck and Co., Inc., P.O. Box 4, WP42-209, WestPoint, PA 19486-0004. Telephone:  215-652-0480. Fax:  215-993-5798.E-mail:  michael_miller1@merck.com.</mods:affiliation>
</k>
<l>
<i>001A54</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>5</n>
<t>6</t>
</g>
<g>
<k>Mitchell D. Miller</k>
<l>
<g>
<k>
<mods:affiliation>Joint Center for Structural Genomics (JCSG)</mods:affiliation>
</k>
<l>
<i>001470</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>001470</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Stanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California</mods:affiliation>
</k>
<l>
<i>001470</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>3</n>
<t>11</t>
</g>

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021